RI
RTW Investments Portfolio holdings
AUM
$7.02B
1-Year Return
28.16%
This Quarter Return
-12.67%
1 Year Return
+28.16%
3 Year Return
+245.48%
5 Year Return
+425.65%
10 Year Return
+5,642.23%
AUM
$1.68B
AUM Growth
-$191M
(-10%)
Cap. Flow
+$138M
Cap. Flow
% of AUM
8.2%
Top 10 Holdings %
Top 10 Hldgs %
55%
Holding
67
New
15
Increased
26
Reduced
11
Closed
7
Top Buys
| 1 |
Zimmer Biomet
ZBH
|
$55.3M |
| 2 |
BLU
BELLUS Health Inc.
BLU
|
$26.9M |
| 3 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
$26.3M |
| 4 |
Insulet
PODD
|
$18.3M |
| 5 |
PTC Therapeutics
PTCT
|
$17.4M |
Top Sells
| 1 |
Alnylam Pharmaceuticals
ALNY
|
$34.6M |
| 2 |
Illumina
ILMN
|
$30.2M |
| 3 |
Arrowhead Research
ARWR
|
$29.7M |
| 4 |
OrthoPediatrics
KIDS
|
$14.7M |
| 5 |
Myriad Genetics
MYGN
|
$10.5M |
Sector Composition
| 1 | Healthcare | 94.09% |
| 2 | Communication Services | 0.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
argenx
ARGX
$44.9B
| $3.59M | 0.21% |
31,516
+68
| +0.2% | +$7.75K |
|
52
CareDx
CDNA
$697M
| $3.5M | 0.21% |
154,951
+335
| +0.2% | +$7.57K |
|
53
Clearside Biomedical
CLSD
$27.5M
| $2.36M | 0.14% |
+3,747,699
| New | +$2.36M |
|
54
Solid Biosciences
SLDB
$433M
| $1.51M | 0.09% |
9,703
+21
| +0.2% | +$3.26K |
|
55
Neuronetics
STIM
$219M
| $1.39M | 0.08% |
167,728
-546
| -0.3% | -$4.54K |
|
|
MOTS
56
DELISTED
Motus GI Holdings, Inc. Common Stock
MOTS
| $1.34M | 0.08% |
2,252
-1,502
| -40% | -$892K |
|
|
OPTN
57
DELISTED
OptiNose
OPTN
| $615K | 0.04% |
5,854
+13
| +0.2% | +$1.37K |
|
|
LVGO
58
DELISTED
Livongo Health, Inc. Common Stock
LVGO
| $262K | 0.02% |
+15,000
| New | +$262K |
|
59
10x Genomics
TXG
$1.69B
| $252K | 0.02% |
+5,000
| New | +$252K |
|
|
60
Arrowhead Research
ARWR
$3.87B
| – | – |
-1,120,346
| Closed | -$29.7M |
|
|
CMMB
61
Chemomab Therapeutics
CMMB
$15.8M
| – | – |
-811
| Closed | -$233K |
|
|
62
Illumina
ILMN
$15.5B
| – | – |
-84,296
| Closed | -$30.2M |
|
|
63
OrthoPediatrics
KIDS
$519M
| – | – |
-376,647
| Closed | -$14.7M |
|
|
64
Myriad Genetics
MYGN
$632M
| – | – |
-376,586
| Closed | -$10.5M |
|
|
VRAY
65
DELISTED
ViewRay, Inc.
VRAY
| – | – |
-159,247
| Closed | -$1.4M |
|
|
VIVE
66
DELISTED
VIVEVE MED INC
VIVE
| – | – |
-4,481
| Closed | -$1.7M |
|